Israel Englander’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.6M Buy
1,199,940
+659,647
+122% +$48.1M 0.03% 546
2026
Q1
$35.3M Buy
540,293
+42,879
+9% +$3.18M 0.01% 1097
2025
Q4
$39.4M Sell
497,414
-180,437
-27% -$13.8M 0.02% 979
2025
Q3
$49.5M Buy
677,851
+76,507
+13% +$5.61M 0.02% 882
2025
Q2
$45.6M Buy
+601,344
New +$42.6M 0.02% 880
2025
Q1
Sell
-212,145
Closed -$15.8M 6503
2024
Q4
$14M Sell
212,145
-345,933
-62% -$24.2M 0.01% 1840
2024
Q3
$38.9M Sell
558,078
-207,693
-27% -$12.5M 0.02% 996
2024
Q2
$40.5M Buy
765,771
+677,940
+772% +$41.2M 0.02% 942
2024
Q1
$6.11M Buy
+87,831
New +$6.57M ﹤0.01% 2671

Other funds holding SOLV

Israel Englander's SOLV Position: Q2 2026 in Review

Israel Englander increased its Solventum (SOLV) stake by 122% in Q2 2026, buying an estimated $48.1M and bringing the position to 1,199,940 shares worth $92.6M. The position accounts for 0.03% of the portfolio, ranked #546.

Israel Englander first reported a position in SOLV in Q1 2024 and has held it in 9 quarters since. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Israel Englander held 1,199,940 shares of Solventum worth $92.6M as of Q2 2026.
  • Israel Englander bought 659,647 Solventum shares in Q2 2026, an estimated $48.1M.
  • Solventum made up 0.03% of Israel Englander's portfolio in Q2 2026, its #546 holding.
  • Israel Englander first reported a position in Solventum in Q1 2024 and has held it in 9 quarters since.
  • 873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.